SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 19th, 2004 • Novavax Inc • Biological products, (no disgnostic substances) • New York
SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of July 16, 2004 by and among Novavax, Inc., a Delaware corporation, with headquarters located at 8320 Guilford Road, Suite C, Columbia, Maryland 21046 (the “Company”), and the investors listed on the Schedule of Buyers attached hereto (individually, a “Buyer” and collectively, the “Buyers”).
NOVAVAX, INC. COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • July 19th, 2004 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
THIS COMMON STOCK PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of July 16, 2004, by and between Novavax, Inc., a Delaware corporation (the “Company”), and Joseph R. Gregory, an individual resident of the State of Tennessee (such investor, or his nominee, the “Investor”).
EXCHANGE AGREEMENTExchange Agreement • July 19th, 2004 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
THIS EXCHANGE AGREEMENT (this “Agreement”) is entered into as of July 16, 2004, by and among NOVAVAX, INC., a Delaware corporation (the “Company”), KING PHARMACEUTICALS, INC., a Tennessee corporation (“King”), and PARKEDALE PHARMACEUTICALS, INC., a Michigan corporation (“Parkedale”).
TERMINATION AGREEMENTTermination Agreement • July 19th, 2004 • Novavax Inc • Biological products, (no disgnostic substances) • Delaware
THIS TERMINATION AGREEMENT (this “Agreement”) is made as of July 19, 2004, by and among KING PHARMACEUTICALS, INC., a Tennessee corporation (“King”), PARKEDALE PHARMACEUTICALS, INC., a Michigan corporation (“Parkedale”), and NOVAVAX, INC., a Delaware corporation (“Novavax”).
